“18F-FET and 18F-choline PET/CT in patients with MRI-presumed low-grade gliomas: a pilot study” article
Ana Mišir Krpan, Anja Tea Golubić, Maja Baučić, Jakob Nemir, Goran Mrak, Marijan Žuvić, Dražen
Menu
- EN
Competence in Nuclear-Medicine.
At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.
Since its foundation in 1994, IASON has constantly introduced new and innovative products and has made them accessible to laboratory and nuclear medicine.
In the laboratory medicine branch, IASON has made it its business to select the newest and most modern radio and enzyme immunoassays on the world market. Moreover, the most important products are manufactured for IASON under licence and sold as their own products.
By loading the video, you agree to YouTube's privacy policy.
Learn more
26
Years of experience
56
Employees
1st
2019 European Business Awards
15
Full market approvals in EU countrys
Innovative products for our customers
01
Radiopharmaceuticals
02
Medicinal Products
03
IASOwater
04
Aircrew Dosimetry
Together with medicine and competence, IASON serves the patient
The core competencies of IASON include concepts for the distribution of pharmaceuticals with a very short shelf-life and for the increase in efficiency of the process sequences. Furthermore, we implement safety tools in the case of radioactivity and to guarantee modern hygienic standards for the handling of pharmaceuticals.
Technology
Consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore com generate.
Research
Consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore com generate.
Consulting
Consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore com generate.
Advantages of PET pharmaceuticals
01
Change of therapeutic concept
02
Better outcome and prognosis of patient
03
Increase of life expectancy and quality of life
04
Cost optimization of patient care
For oncological and neurological indications.
Innovative products for our customers
Precisely in the case of PET radiopharmaceuticals, our guiding principle has in particular been well established: Together with medicine, IASON serves the patient. These radiopharmaceuticals are special products which are manufactured and supplied in close cooperation with the physician applying the product (with extensive patient information).
Career at IASON
Looking for a job in an innovative company? IASON offers an exciting range of careers at the forefront of scientific innovation. Learn more about IASON and the opportunities available.
Adipisci qui natus expedita aut eum aut. Et ut repellendus ea quis autem reprehenderit volu ptatem. Amet totam dolor is voluptates a tenetur sit. Qui asperiores excepturi perspiciatis totam rerum volup tatem et neque pariatur. Vivamus interdum porta turpis at ornare Fugiat qui illum sequi ea qui eos fugit mauris!
Christoph Artner – CEO of IASON
The latest news
from IASON
Marina Hodolic and our scientific collaborators from Linz, Austria published a new article: Giant silent corticotrope pituitary adenoma in a patient with complicated clinical course
Iason would like to announce that great scientific team from Kepler University Hospital, Linz, Austria
Qualified Person/Sachkundige Person (m/w/d) – Linz
An unserem pharmazeutischen Produktionsstandort in Linz besetzen wir die Position der Qualified Person/Sachkundigen Person (m/w/d)
Do you want to know more about our products?
For inquiries please contact us, we will be happy to assist you!
